Artificial Heart In 2004, the United States Food and Drug Administration (FDA) approved the first implantable temporary artificial heart, which keeps heart failure patients alive until they can receive a transplant. The FDA approval was based in large part on the results of a study of the artificial heart in 81 patients at high risk for death due to irreversible biventricular cardiac failure. The rate of survival to transplantation was 79 percent, compared with 46 percent in a group of control patients who did not receive the artificial heart. The one-year survival rate among patients who received the artificial heart was 70 percent, compared with 31 percent among the controls. The one and five year survival rates among transplant recipients were 86 percent and 64 percent.
See also: Heart Valve Surgery Heart Transplants and Statistics Open-Heart Surgery Statistics |
|
|||||||||||||||||||||||||||||
| ||||